Trusted by 10,000+ Scientists since 2006

Olaparib (AZD2281)

ON SALE

PARP inhibitor

0 Customer Reviews
Catalog No. A10111

Availability:Stock in USAIn stock

Product Name Catalog No. Price Qty
Olaparib 10mg A10111-10

Regular Price: $40.00

Special Price: $36.00

Olaparib 25mg A10111-25

Regular Price: $60.00

Special Price: $54.00

Olaparib 50mg A10111-50

Regular Price: $70.00

Special Price: $63.00

Olaparib 100mg A10111-100

Regular Price: $90.00

Special Price: $81.00

Olaparib (AZD2281) 10mM * 1mL in DMSO A10111-10mM-D

Regular Price: $76.00

Special Price: $68.40

Products are for laboratory research use only. Not for human use. We do not sell to patients.

Olaparib (AZD2281)

Double click on above image to view full picture

Zoom Out
Zoom In
Publications citing Adooq Products
Olaparib (AZD2281) Citations (9)
  • Alvin Z.Lu, .et al. Enabling drug discovery for the PARP protein family through the detection of mono-ADP-ribosylation, Biochem Pharmacol, 2019, May 7. pii: S0006-2952(19)30171-6 PMID: 31075269
  • Bian C, .et al. NADP+ is an endogenous PARP inhibitor in DNA damage response and tumor suppression, Nat Commun, 2019, Feb 11;10(1):693 PMID: 30741937
  • HC de Silva, .et al. IGFBP-3 interacts with NONO and SFPQ in PARP-dependent DNA damage repair in triple-negative breast cancer, Cell Mol Life Sci, 2019, 1-16 PMID: 30725116
  • Kamada Y, .et al. Castalagin and vescalagin purified from leaves of Syzygium samarangense (Blume) Merrill & L.M. Perry: Dual inhibitory activity against PARP1 and DNA topoisomerase II, Fitoterapia, 2018, Sep;129:94-101 PMID: 29928967
  • 2018, .et al. Augmentation of the therapeutic efficacy of WEE1 kinase inhibitor AZD1775 by inhibiting the YAP-E2F1-DNA damage response pathway axis, FEBS Open Bio, 2018, Jun; 8(6): 1001-1012 PMID: 29928579
  • Hirosumi Tamura, .et al. Evaluation of anticancer agents using patient-derived tumor organoids characteristically similar to source tissues, Oncol Rep, 2018, Aug; 40(2): 635-646 PMID: 29917168
  • Hiro Sato, .et al. DNA double-strand break repair pathway regulates PD-L1 expression in cancer cells, Nat Commun, 2017, 8: 1751 PMID: 29170499
  • Charles-André Philip, .et al. Inhibition of PI3K-AKT-mTOR pathway sensitizes endometrial cancer cell lines to PARP inhibitors, BMC Cancer, 2017, 17: 638 PMID: 28886696
  • Rulina AV, .et al. Distinct outcomes of CRL-Nedd8 pathway inhibition reveal cancer cell plasticity, Cell Death Dis, 2016, Dec 1;7(12):e2505 PMID: 27906189

Write Your Own Review

Only registered users can write reviews. Please, log in or register


Keywords:buy Olaparib (AZD2281) | Olaparib (AZD2281) Supplier | purchase Olaparib (AZD2281) | Olaparib (AZD2281) cost | Olaparib (AZD2281) manufacturer | order Olaparib (AZD2281) | Olaparib (AZD2281) distributor | buy 763113-22-0| 763113-22-0 Supplier | purchase 763113-22-0 | 763113-22-0 cost | 763113-22-0 manufacturer | order 763113-22-0 | 763113-22-0 distributor